缩写名/全名 |
PROG MOL BIOL TRANSL
Progress in Molecular Biology and Translational Science |
||||||||||||||||||||
ISSN号 | 1877-1173 | ||||||||||||||||||||
研究方向 | BIOCHEMISTRY & MOLECULAR BIOLOGY- | ||||||||||||||||||||
影响因子 | 2015:3.364, 2016:2.984, 2017:3.074, 2018:2.819, 2019:4.074, | ||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||
出版周期 | |||||||||||||||||||||
年文章数 | 111 | ||||||||||||||||||||
出版年份 | 0 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||
投稿链接 | |||||||||||||||||||||
投稿官网 | http://www.sciencedirect.com/science/bookseries/18771173 | ||||||||||||||||||||
h-index | 88 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1877-1173%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Marine glycan-derived therapeutics in China. Author: Gao Y1, Zhang L2, Jiao W3. Journal: Prog Mol Biol Transl Sci. 2019;163:113-134. doi: 10.1016/bs.pmbts.2019.02.006. Epub 2019 Mar 26. PubMed DOI |
2. | An overview of fungal glycan-based therapeutics. Author: Yang D1, Zhou Z2, Zhang L3. Journal: Prog Mol Biol Transl Sci. 2019;163:135-163. doi: 10.1016/bs.pmbts.2019.02.001. Epub 2019 Mar 21. PubMed DOI |
3. | Ganoderma sinense polysaccharide: An adjunctive drug used for cancer treatment. Author: Zhang Y1, Jiang Y2, Zhang M3, Zhang L4. Journal: Prog Mol Biol Transl Sci. 2019;163:165-177. doi: 10.1016/bs.pmbts.2019.02.008. Epub 2019 Mar 25. PubMed DOI |
4. | Ganoderma lucidum polysaccharide used for treating physical frailty in China. Author: Zeng P1, Chen Y2, Zhang L3, Xing M4. Journal: Prog Mol Biol Transl Sci. 2019;163:179-219. doi: 10.1016/bs.pmbts.2019.02.009. Epub 2019 Mar 26. PubMed DOI |
5. | Low molecular weight heparins and their clinical applications. Author: Hao C1, Sun M2, Wang H3, Zhang L4, Wang W5. Journal: Prog Mol Biol Transl Sci. 2019;163:21-39. doi: 10.1016/bs.pmbts.2019.02.003. Epub 2019 Mar 25. PubMed DOI |
6. | The biological activities of the antitumor drug Grifola frondosa polysaccharide. Author: He Y1, Zhang L2, Wang H3. Journal: Prog Mol Biol Transl Sci. 2019;163:221-261. doi: 10.1016/bs.pmbts.2019.02.010. Epub 2019 Mar 25. PubMed DOI |
7. | Molecular basis for Poria cocos mushroom polysaccharide used as an antitumor drug in China. Author: Li X1, Ma L2, Zhang L3. Journal: Prog Mol Biol Transl Sci. 2019;163:263-296. doi: 10.1016/bs.pmbts.2019.02.011. Epub 2019 Apr 1. PubMed DOI |
8. | Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China. Author: Zhang M1, Zhang Y2, Zhang L2, Tian Q3. Journal: Prog Mol Biol Transl Sci. 2019;163:297-328. doi: 10.1016/bs.pmbts.2019.02.013. Epub 2019 Apr 4. PubMed DOI |
9. | The efficacy of Polyporus Umbellatus polysaccharide in treating hepatitis B in China. Author: Guo Z1, Zang Y2, Zhang L3. Journal: Prog Mol Biol Transl Sci. 2019;163:329-360. doi: 10.1016/bs.pmbts.2019.03.012. Epub 2019 Apr 9. PubMed DOI |
10. | Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. Author: Dou H1, Chang Y2, Zhang L3. Journal: Prog Mol Biol Transl Sci. 2019;163:361-381. doi: 10.1016/bs.pmbts.2019.03.001. Epub 2019 Apr 1. PubMed DOI |
|
|